Table 4

Relationships between 6-month post-treatment health outcomes and 12-month post-treatment PTSD scores

Unadjusted β (95% CI)Adjusted β (95% CI)
Model 1Model 2Model 3
Depression (PHQ-9)0.80 (0.62 to 0.98)*0.79 (0.60 to 0.98)*0.35 (0.07 to 0.63)*0.15 (−0.12 to 0.41)
Generalised anxiety (GAD-7)0.95 (0.73 to 1.18)*0.93 (0.70 to 1.16)*0.26 (−0.10 to 6.63)0.05 (−0.40 to 0.29)
Anger (DAR-5)0.52 (0.30 to 0.75)*0.55 (0.32 to 0.78)*0.08 (−0.33 to 0.17)0.03 (−0.38 to 0.07)
Alcohol (AUDIT)0.24 (0.07 to 0.42)*0.26 (0.07 to 0.44)*0.19 (0.04 to 0.35)*0.18 (0.03 to 0.32)*
Functioning (WSAS)0.60 (0.47 to 0.73)*0.61 (0.47 to 0.74)*0.37 (0.20 to 0.54)*0.24 (0.08 to 0.41)*
  • Model 1 is β adjusted for age and employment status. Model 2 is additionally adjusted for 6-month health outcomes listed above. Model 3, in addition to Model 2, is adjusted for 6-month post-treatment PSS-I score.

  • *p≤0.05.

  • AUDIT, Alcohol Use Disorders Identification Test; DAR-5, five-item Dimensions of Anger Reactions; GAD-7, Generalised Anxiety Disorders measure; PSS-I, PTSD Symptom Scale Interview; PTSD, post-traumatic stress disorder; WSAS, Work and Social Adjustment Scale.